DOCS News and Press, Doximity Inc. Class A From 12/08/25

2025-12-08 08:46:52 ET Thesis Doximity, Inc. ( DOCS ) reported a 2Q26 non-GAAP EPS of $0.45. It's a figure that beat estimates by about $0.07. Revenue also came in above expectations, beating consensus by $10.91 with a figure of $168.5 million. Revenue was also up 23.2% year...

2025-12-07 06:25:14 ET I have been tracking Doximity ( DOCS ) since the IPO, and frankly, it has been a frustrating one. The company prints cash and dominates its niche but trades like a penny stock the moment sentiment shifts.... Read the full article on Seeking Alpha F...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 17.5% to $0.037 on volume of 1,002,607,027 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.3% to $2.985 on volume of 267,033,397 shares Warner Bros. Discovery Inc. (WB...

2025-11-25 13:49:40 ET Relative performance and valuations are the foundation of most professional investment strategies. When investors look at how the Health Care Select Sector SPDR Fund ETF (XLV) has fallen in comparison to the broader S&P 500, it’s clear that there needs ...

2025-11-25 09:02:06 ET Issued on behalf of Aleen Inc. VANCOUVER – USA News Group News Commentary – The race to integrate artificial intelligence into healthcare has reached record investment levels, with AI-powered healthcare and biotech startups ra...

2025-11-21 11:15:38 ET More on Doximity Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript Doximity: Valuation Is Too Expensive For My Liking Doximity falls despite Q2 beat amid uncertainty over client budgets Doximity outlines 13% full-year revenue growt...

2025-11-21 05:15:04 ET Raymond James analyst issues STRONG BUY recommendation for DOCS on November 21, 2025 10:00AM ET. The previous analyst recommendation was Outperform. DOCS was trading at $46.42 at issue of the analyst recommendation. The overall analyst consensus : ...

2025-11-10 11:19:27 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way XLV: Market Overreaction Could Drive Double Digit Shareholder Yield XLV Vs. IHE: Will Pharmaceuticals Outperform...

2025-11-10 08:06:22 ET More on OpenAI Wall Street Lunch: OpenAI Surpasses 1M Global Business Consumers Wall Street Lunch: Amazon, OpenAI Sign $38B Deal For Nvidia GPU Access Wall Street Lunch: Broadcom Surges On Deal With OpenAI For Custom AI Accelerators Ope...

2025-11-07 13:46:57 ET More on Doximity Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript Doximity: Valuation Is Too Expensive For My Liking Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption Doximity Non-GAAP E...